Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M40,259Revenue $M10,235Net Margin (%)16.6Z-Score3.3
Enterprise Value $M44,102EPS $3.6Operating Margin %20.8F-Score4
P/E(ttm))25.6Cash Flow Per Share $5.3Pre-tax Margin (%)19.8Higher ROA y-yN
Price/Book4.210-y EBITDA Growth Rate %6.6Quick Ratio1.5Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %6.1Current Ratio2.0Lower Leverage y-yN
Price/Cash Flow11.0y-y EBITDA Growth Rate %7.1ROA % (ttm)8.5Higher Current Ratio y-yN
Dividend Yield %1.4Insider Buy (3m)0ROE % (ttm)18.4Less Shares Outstanding y-yY
Payout Ratio %35.0Shares Outstanding M451ROI % (ttm)10.6Gross Margin Increase y-yN

Gurus Latest Trades with COV

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
COVYacktman Focused Fund 2014-06-30 Sold Out -0.62%$69.03 - $91.24
($74.56)
$ 89.2920%Sold Out0
COVYacktman Fund 2014-06-30 Sold Out -0.56%$69.03 - $91.24
($74.56)
$ 89.2920%Sold Out0
COVJoel Greenblatt 2014-03-31 Buy $66.35 - $72.5
($69.62)
$ 89.2928%New holding, 3746 sh.3,746
COVRay Dalio 2014-03-31 Reduce-0.02%$66.35 - $72.5
($69.62)
$ 89.2928%Reduce -41.8%47,058
COVVanguard Health Care Fund 2013-12-31 Add0.22%$59.82 - $68.42
($65.08)
$ 89.2937%Add 24.79%4,994,700
COVRay Dalio 2013-12-31 Buy 0.04%$59.82 - $68.42
($65.08)
$ 89.2937%New holding, 80858 sh.80,858
COVJohn Keeley 2013-12-31 Reduce-0.06%$59.82 - $68.42
($65.08)
$ 89.2937%Reduce -52.66%44,520
COVJoel Greenblatt 2013-12-31 Sold Out -0.03%$59.82 - $68.42
($65.08)
$ 89.2937%Sold Out0
COVJoel Greenblatt 2013-09-30 Reduce-0.08%$57.12 - $63.8
($61.08)
$ 89.2946%Reduce -64.08%16,584
COVVanguard Health Care Fund 2013-06-30 Add0.37%$50.69 - $56.84
($54.09)
$ 89.2965%Add 66.94%4,002,600
COVJoel Greenblatt 2013-06-30 Buy 0.12%$50.69 - $56.84
($54.09)
$ 89.2965%New holding, 46170 sh.46,170
COVRonald Muhlenkamp 2013-06-30 Reduce-2.78%$50.69 - $56.84
($54.09)
$ 89.2965%Reduce -53.5%174,170
COVJean-Marie Eveillard 2013-06-30 Reduce-0.16%$50.69 - $56.84
($54.09)
$ 89.2965%Reduce -99.79%1,500
COVLeon Cooperman 2013-06-30 Sold Out -0.04%$50.69 - $56.84
($54.09)
$ 89.2965%Sold Out0
COVRay Dalio 2013-06-30 Sold Out -0.04%$50.69 - $56.84
($54.09)
$ 89.2965%Sold Out0
COVLeon Cooperman 2013-03-31 Buy 0.93%$52.59 - $61.79
($57.3)
$ 89.2956%New holding, 887300 sh.887,300
COVJean-Marie Eveillard 2013-03-31 Reduce-0.06%$52.59 - $61.79
($57.3)
$ 89.2956%Reduce -30.95%700,891
COVRay Dalio 2013-03-31 Reduce-0.01%$52.59 - $61.79
($57.3)
$ 89.2956%Reduce -22.49%60,996
COVRay Dalio 2012-12-31 Buy 0.05%$48.6 - $55.05
($52.01)
$ 89.2972%New holding, 78696 sh.78,696
COVJean-Marie Eveillard 2012-12-31 Reduce-0.06%$48.6 - $55.05
($52.01)
$ 89.2972%Reduce -21.14%1,014,988
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

COV is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
COV Yacktman Focused Fund 2014-06-30000Sold Out
COV Yacktman Fund 2014-06-30000Sold Out
COV Joel Greenblatt 2014-03-313,74600New Buy
COV Vanguard Health Care Fund 2014-03-314,994,7001.111
COV Jean-Marie Eveillard 2014-03-311,50000
COV Ronald Muhlenkamp 2014-03-31181,4550.042.4-0.1%
COV Donald Yacktman 2014-03-311,784,8250.40.55-0.31%
COV John Keeley 2014-03-3143,7700.010.06-1.68%
COV Dodge & Cox 2014-03-31101,5170.020.01-8.8%
COV Mario Gabelli 2014-03-31543,5600.120.22-12.63%
COV Ray Dalio 2014-03-3147,0580.010.03-41.8%
Premium Most recent portfolio changes are included for Premium Members only!


COV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ALMEIDA JOSE EPresident and Chief Executive 2014-06-16Sell51,166$92.05-3.43view
King Brian DouglasVice President 2014-04-29Sell15,569$70.1126.79view
Dockendorff Charles JEVP & CFO 2014-03-28Sell90,730$72.522.61view
ALMEIDA JOSE EPresident and Chief Executive 2014-02-28Sell50,000$7223.46view
Lannum Coleman N IIIVice President 2014-02-18Sell3,200$71.424.5view
BROWN RICHARD G JRVice President and Controller 2014-02-13Sell4,000$7125.2view
Lannum Coleman N IIIVice President 2014-02-12Sell961$70.2226.59view
Wehrly Peter LSenior Vice President 2014-02-11Sell8,286$69.9727.04view
Hanson Bryan CSenior Vice President 2014-02-11Sell32,480$69.9727.04view
King Brian DouglasVice President 2014-02-11Sell17,946$7026.99view

Press Releases about COV :

Quarterly/Annual Reports about COV:

News about COV:

Articles On GuruFocus.com
Steven Romick's Top Five Stocks Jul 11 2014 
American Water Works - Nice Steady Upward Jun 21 2014 
Major British Companies Lead Top Guru-Held UK and Ireland Stocks Jun 10 2014 
4 Top Stocks in the Medical Device Sector Apr 11 2014 
Weekly Insider Sells Highlight: CUK, CBI, COV, DWRE Mar 30 2014 
Weekly CFO Sells Highlight: Chicago Bridge and Iron Company, Covidien PLC, Carnival PLC, Google Inc. Mar 30 2014 
We Are Confident About Baxter's Plan to Create Two Separate Health Care Companies Mar 28 2014 
Can Malllinckrodt Keep on Crushing Expectations? Mar 19 2014 
Weekly 52-Week Highs Highlight: COV, EQT, XLNX, TEVA Mar 03 2014 
Top Five Guru-Held UK and Ireland Stocks Dec 11 2013 

More From Our Partners
FT: 25 More Firms May Seek Tax Breaks Overseas Jul 22 2014 - FOXBUSINESS

More From Other Websites
COVIDIEN PLC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Jul 22 2014
7:01 am Covidien announced that Bryan Hanson, currently group president Medical Devices & US, will... Jul 22 2014
Covidien Announces Leadership Appointment Jul 22 2014
[video] Covidien, Williams Companies Offer Dynamic Dividend Plays Jul 21 2014
Tax inversions allow firms to avoid state taxes Jul 21 2014
Covidien Unveils Advanced Ablation Device for Liver Tumor Jul 17 2014
COVIDIEN PLC Financials Jul 17 2014
Covidien downgraded by Needham Jul 17 2014
Covidien Declares Quarterly Cash Dividend Jul 16 2014
Covidien (COV) Showing Signs Of Being Water-Logged And Getting Wetter Jul 16 2014
Treasury Urges End to Foreign Tax Flights, but Quick Action Is Unlikely Jul 16 2014
Covidien Makes Liver Tumor Ablation More Predictable Jul 16 2014
Stryker Continues Growth Spree via Acquisitions Jul 14 2014
Announcement under Irish Takeover Rules Relevant Securities in Issue – July 14, 2014 Jul 14 2014
COVIDIEN PLC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events,... Jul 11 2014
Covidien Launches EverFlex™ Self-expanding Peripheral Stent with Entrust™ Delivery System in... Jul 10 2014
Covidien Ranks First in IR Magazine US Top 100 Jul 09 2014
Deutsche Bank Reiterates On Medtronic And Covidien Amid Acquisition Proposal Jul 08 2014
Covidien (COV) is in Overbought Territory: What's Next? Jul 01 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide